Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bladder cancer diagnosed incident cases across 8MM to reach 0.34 mn in 2033
Older adults aged 60 years and above accounted for almost 87 per cent of the diagnosed incident cases of bladder cancer in the 8MM…
Biocon and Dr Reddy’s featured in Science Magazine’s Top Employers List
This year’s ranking is based on a comprehensive web-based survey of about 6,400 respondents
PM Modi inaugurates Lyfius Pharma’s flagship Penicillin-G facility
Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma invested ₹2,500 crores in its Penicillin-G (Pen-G) facility at…
Upskilling and reskilling: Key to driving innovation in India’s pharma sector
A skilled workforce is critical to addressing the complexities of modern drug development and personalised medicine.
Delhi High Court reinstates Injunction stopping sale of Zydus’ Sigrima
The decision, made in response to Roche's appeal on October 16, 2024, reversed an earlier order from October 9, 2024
MRP of 3 anti-cancer drugs to come down due to exemption from custom duty and reduction in GST
NPPA has issued an OM directing the concerned manufacturers to reduce the maximum retail price on Trastuzumab, Osimertinib and…
Cardiovascular benefits can increase Rybelsus’ competitiveness over other oral GLP-1RAs
The market for oral GLP-1RAs is expanding, and Rybelsus’ latest results showed its benefits in reducing the risk in cardiovascular…
Dr Reddy’s launches BixiBat to treat chronic constipation in India
Elobixibat was approved by the CDSCO after submission of the company's successful Phase-3 clinical trial to the Subject Expert…
Lupin to focus on development of inhalers with near-zero global warming potential propellants
This initiative aims to provide patients with pressurised metered dose inhalers (pMDIs) that maintain the same efficacy and…
Emcure launches Emcutix Biopharmaceuticals to expand its dermatology offerings
Emcutix will be spearheaded by G Sathya Narayanan and will have a dedicated team. The newly set up entity plans to expand Emcure’s…